Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TPST Relative to the S&P 500

TPST Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Tempest Therapeutics Inc. (NASD:TPST) seasonal charts above shows that a Buy Date of September 30 and a Sell Date of January 22 has resulted in a geometric average return of 1.13% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 54.71% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

To download TPST seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TPST